We would love to hear your thoughts about our site and services, please take our survey here.
I wonder if the BoD have received the message that long suffering shareholders aren't keen on a raise given the drop (again) today. I hope they have something up their sleeve before the AGM to restore confidence here.
: )
Don’t really have anything to say but don’t want @masterblasts usual idiotic post to be at the top on the thread : )
Well, LBPS has bounced back at least.
https://twitter.com/soundsrisky/status/1534214766222360579?s=21&t=NCE2uacJAz2saFljBE0i1w
Remember a few weeks back when a 500k buy order popped up at 31p? Appeared and disappeared a few times. Wonder if MM’s are trying to fill that or a similar large order. There seems to be clear intent to drive this down currently.
Yes, @Boonco, though we are aware that Blautix news (potential for sale/collab) and Vaccine news (potential milestone payment) could come between now and the end of the year. As could a buyout and many more trial data readouts. The next tranche would see funding extending through that period so would take away a significant concern and reduce need for a raise, which is currently weighing on the SP and being used by shorters to de-ramp.
No, I wasn't serious : )
Did wonder a few weeks back if it was broken though.
Despite the incredibly positive trial data which looks at present like it might be replicated across multiple diseases just zoom out and take a look at the chart for the past 5 years to see where we currently sit in terms of share price. That will tell you all you need to know. The only thing holding this back is finance IMO. News on Oxford, which Duncan has confirmed he is in talks about many weeks ago (i.e. its due), and this will explode. Given positive results I see no reason why Oxford would not wish to retain close ties and continued support for 4D.
Yes, keen to hoover up shares at this level I think. Drag it out at the same price for days/weeks on end and try to bore PI's out of their shares. Spread has been incredibly tight at times. Hard to see what is sell and what is buy. I know its a common comment from PI's that the 'market makers' are up to something and its often not the case, but here I genuinely think it is.
Happened on a number of days recently, notably last Wednesday and again today but lots of decent sized round number buys 15,000, 20,000 30,000 whilst we remain held in a VERY tight range. There is clearly some manipulation in action, though I do think that the brakes will be released at some point, when least expected.
Maybe just testing the RNS machine before some big news! : )
Though nothing spectacular. Employee options. Small number.
The clown has returned. Again, new posters/investors, check out @Masterblasts posting history for a taste of how much nonsense he spouts. Definitely one to ignore - most long term holders blocked him a long time ago. I would advise the same.
My advice to any new investors is to look back at @Masterblasts posting history to see what an absolute clown he is. Clinging onto his short in any way he can.
Current share price is bargain of the century to new investors IMO.
Believe me! I definitely have a lot to lose here. Only want to see this company succeed and hopefully make me a decent sum of money in the process.
Exactly. Let’s say, before the AGM, we had secured agreement for the next tranche of Oxford finance, giving us a cash runway well into 2023. The SP would likely be double where it is now and we would be well funded for some time to come. In that circumstance, voting for resolution 9 is far less concerning as it takes away any need to dilute just to keep the lights on. Instead it might be used for significant growth and opportunity. A raise for that reason (though not 100%) I can live with. A raise just to pay salaries and the bills I cannot. Time for BoD to bring in this US investment we were promised.
For me to have some level of trust and confidence in the BoD I would need to see something of a solution to financing before giving the support of my vote and risk of dilution. This might be, Blautix sale, Oxford Finance, Big Pharma buy-in or other buy-in investment from US/NASDAQ (this was the whole point of listing there wasn’t it?) I know it’s a tough environment, I know XBI has dropped, I’m convinced by the science but what I haven’t seen yet is evidence of further II financial involvement or significant investment. Shareholders have been hit hard and the BoD needs to recognise and address that if they want further support. I’m willing to give it but need convincing - ideally in the form of a rising share price.
Not saying I agree with it. Personally I don’t expect the BoD to use it (certainly not in full) as they haven’t this year, as they are also diluting themselves. I would absolutely like to see some confirmation of Oxford finance or other II funding before considering where to place my vote.
Resolution 9 info via this link; https://twitter.com/soundsrisky/status/1533795654174113793?s=21&t=_gHOjmiEdNQDeDwwb7GJrg
@crl - that's not necessarily the case. Info explaining reasons for resolution 9 states that 'The directors will give consideration to ways in which existing shareholders can participate in such a fundraise, including by way of an open offer.' It does not state that existing shareholders would be excluded.